These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11084688)

  • 21. [Gene therapy and the skin].
    Hengge UR; Bardenheuer W; Doroudi R; Mirmohammadsadegh A
    Ann Dermatol Venereol; 2005 Feb; 132(2):154-63. PubMed ID: 15798569
    [No Abstract]   [Full Text] [Related]  

  • 22. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa.
    Goto M; Sawamura D; Ito K; Abe M; Nishie W; Sakai K; Shibaki A; Akiyama M; Shimizu H
    J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-focusing therapeutic gene delivery with intelligent gene vector swarms: intra-swarm signalling through receptor transgene expression in targeted cells.
    Tolmachov OE
    Artif Intell Med; 2015 Jan; 63(1):1-6. PubMed ID: 25547266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy vector design strategies for the treatment of cancer.
    Dong JY; Woraratanadharm J
    Future Oncol; 2005 Jun; 1(3):361-73. PubMed ID: 16556010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An approach to achieve long-term expression in skin gene therapy.
    Therrien JP; Pfützner W; Vogel JC
    Toxicol Pathol; 2008 Jan; 36(1):104-11. PubMed ID: 18337228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene transfer in human skin with different pseudotyped HIV-based vectors.
    Hachiya A; Sriwiriyanont P; Patel A; Saito N; Ohuchi A; Kitahara T; Takema Y; Tsuboi R; Boissy RE; Visscher MO; Wilson JM; Kobinger GP
    Gene Ther; 2007 Apr; 14(8):648-56. PubMed ID: 17268532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy of cancer: a pilot study of IL-4-gene-modified fibroblasts admixed with autologous tumor to elicit an immune response.
    Lotze MT; Rubin JT; Carty S; Edington H; Ferson P; Landreneau R; Pippin B; Posner M; Rosenfelder D; Watson C
    Hum Gene Ther; 1994 Jan; 5(1):41-55. PubMed ID: 8155771
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetically modified skin to treat disease: potential and limitations.
    Krueger GG; Morgan JR; Jorgensen CM; Schmidt L; Li HL; Kwan MK; Boyce ST; Wiley HS; Kaplan J; Petersen MJ
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):76S-84S. PubMed ID: 7963689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Functional angiogenesis induction in epigastric islet flap rat model after genetic modification of fibroblasts].
    Machens HG; Morgan JR; Berthiaume F; Stefanovich P; Berger AC
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):681-7. PubMed ID: 14518341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo.
    Steinwaerder DS; Lieber A
    Gene Ther; 2000 Apr; 7(7):556-67. PubMed ID: 10819570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides.
    Weber C; Armbruster N; Scheller C; Kreppel F; Kochanek S; Rethwilm A; Steinert AF
    J Gene Med; 2013; 15(3-4):155-67. PubMed ID: 23554302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human artificial chromosome (HAC) vector provides long-term therapeutic transgene expression in normal human primary fibroblasts.
    Kakeda M; Hiratsuka M; Nagata K; Kuroiwa Y; Kakitani M; Katoh M; Oshimura M; Tomizuka K
    Gene Ther; 2005 May; 12(10):852-6. PubMed ID: 15750614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hair follicle stem cell-targeted gene transfer and reconstitution system.
    Sugiyama-Nakagiri Y; Akiyama M; Shimizu H
    Gene Ther; 2006 Apr; 13(8):732-7. PubMed ID: 16397506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The production and applications of genetically modified skin cells.
    Bevan S; Martin R; Mckay IA
    Biotechnol Genet Eng Rev; 1999; 16():231-56. PubMed ID: 10819081
    [No Abstract]   [Full Text] [Related]  

  • 35. Cutaneous Gene Therapy: Problems and Prospects. Proceedings of a meeting. March 23-24, 2000.
    Hum Gene Ther; 2000 Nov; 11(16):2245-312. PubMed ID: 11153469
    [No Abstract]   [Full Text] [Related]  

  • 36. Addition of the human interferon beta scaffold attachment region to retroviral vector backbones increases the level of in vivo transgene expression among progeny of engrafted human hematopoietic stem cells.
    Murray L; Travis M; Luens-Abitorabi K; Olsson K; Plavec I; Forestell S; Hanania EG; Hill B
    Hum Gene Ther; 2000 Sep; 11(14):2039-50. PubMed ID: 11020802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that the mouse 3' kappa light chain enhancer confers position-independent transgene expression in T- and B-lineage cells.
    Xu L; Tsuji K; Mostowski H; Candotti F; Rosenberg A
    Hum Gene Ther; 2003 Dec; 14(18):1753-64. PubMed ID: 14670126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hitchhiker's guide to the T cell.
    Rooney CM
    Nat Med; 2005 Oct; 11(10):1051-2. PubMed ID: 16211037
    [No Abstract]   [Full Text] [Related]  

  • 39. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.
    Bakowska JC; Di Maria MV; Camp SM; Wang Y; Allen PD; Breakefield XO
    Gene Ther; 2003 Sep; 10(19):1691-702. PubMed ID: 12923568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical and biological barriers to viral vector-mediated delivery of genes to the airway epithelium.
    Pickles RJ
    Proc Am Thorac Soc; 2004; 1(4):302-8. PubMed ID: 16113450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.